This finding aligns with its role in Alzheimer’s disease (AD), where S100A9 is implicated in the amyloid–neuroinflammatory cascade, driving chronic microglial activation and neuronal damage. Here, S100A9 is linked to early-onset autosomal dominant Alzheimer disease.